Insider Buying: Retractable Technologies, Inc. (RVP) CEO Purchases 14,937 Shares of Stock

Retractable Technologies, Inc. (NYSEAMERICAN:RVP) CEO Thomas J. Shaw acquired 14,937 shares of the company’s stock in a transaction on Thursday, March 21st. The shares were purchased at an average cost of $0.82 per share, with a total value of $12,248.34. Following the completion of the purchase, the chief executive officer now directly owns 14,002,178 shares of the company’s stock, valued at $11,481,785.96. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of NYSEAMERICAN:RVP remained flat at $$0.70 on Monday. The stock had a trading volume of 77,637 shares, compared to its average volume of 180,507. Retractable Technologies, Inc. has a fifty-two week low of $0.54 and a fifty-two week high of $1.34.

An institutional investor recently raised its position in Retractable Technologies stock. Renaissance Technologies LLC boosted its position in Retractable Technologies, Inc. (NYSEAMERICAN:RVP) by 20.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 692,623 shares of the company’s stock after purchasing an additional 118,723 shares during the quarter. Renaissance Technologies LLC owned approximately 2.12% of Retractable Technologies worth $499,000 at the end of the most recent reporting period.

TRADEMARK VIOLATION WARNING: “Insider Buying: Retractable Technologies, Inc. (RVP) CEO Purchases 14,937 Shares of Stock” was posted by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety medical products for the healthcare industry in the United States and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, and allergy antigen syringes; autodisable syringes; IV catheters; blood collection tube holders; and blood collection sets, as well as Patient Safe products, including syringes and Luer caps.

See Also: What moving averages are used to define a golden cross?

Insider Buying and Selling by Quarter for Retractable Technologies (NYSEAMERICAN:RVP)

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with's FREE daily email newsletter.